FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis

Hua-Chuan Zheng _ and Li-Li Liu

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:108261-108273. https://doi.org/10.18632/oncotarget.22369

Metrics: PDF 1317 views  |   HTML 2985 views  |   ?  


Hua-Chuan Zheng1 and Li-Li Liu2

1Department of Experimental Oncology and Animal Center, Shengjing Hospital of China Medical University, Shenyang 110004, China

2Department of Pathology, Harbin Medical University-Daqing, Daqing 163319, China

Correspondence to:

Hua-Chuan Zheng, email: [email protected]

Keywords: FHIT, gastric cancer, meta-analysis, bioinformatics analysis

Received: August 01, 2017     Accepted: October 03, 2017     Published: November 03, 2017


FHIT (fragile histine triad) acts as diadenosine P1, P3-bis (5'-adenosyl)-triphosphate adenylohydrolase involved in purine metabolism, and induces apoptosis as a tumor suppressor. We performed a systematic meta- and bioinformatics analysis through multiple online databases up to March 14, 2017. The down-regulated FHIT expression was found in gastric cancer, compared with normal mucosa and dysplasia (p < 0.05). FHIT expression was negatively with depth of invasion, lymph node metastasis, distant metastasis, TNM staging and dedifferentiation of gastric cancer (p < 0.05). A positive association between FHIT expression and favorable overall survival was found in patients with gastric cancer (p < 0.05). According to Kaplan-Meier plotter, we found that a higher FHIT expression was negatively correlated with overall and progression-free survival rates of all cancer patients, even stratified by aggressive parameters (p < 0.05). These findings indicated that FHIT expression might be employed as a potential marker to indicate gastric carcinogenesis and subsequent progression, even prognosis.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22369